This year's conference is expected to attract over 30,000 innovators, investors, and technology leaders from around the world. From AI and quantum computing to life sciences and digital healthcare, the agenda for London Tech Week delves into some of the most cutting-edge industries today.

At this year's specially established Deep Tech Stage, life sciences and healthcare innovation have become one of the most closely watched topics. Among them, Beijing Xutang Biotech [1], a high-tech Chinese enterprise, made a unique debut on the international stage to showcase its brand FuDe. It showed the world a new health management paradigm that integrates millennia of traditional Chinese medicine wisdom with modern artificial intelligence technology.

Beijing Xutang Biotech Co., Ltd., a high-tech enterprise specializing in the digitalization of traditional Chinese medicine, made its debut at London Tech Week 2026. (AI-generated image)

Prevention Before Cure: Managing Sub-Health Through "Treating the Unborn Illness"

Large proportions of the global population live in a sub-healthy grey area between health and illness: fatigue, insomnia, mood fluctuations, digestive discomfort… These symptoms don't meet clinical diagnostic thresholds, yet they steadily erode the quality of modern life.

Traditional Chinese Medicine (TCM) has long embraced the philosophical concept of "preventive care" — the idea that attending to the body's balance before symptoms escalate is preferable to treating illness after the fact. Viewed through a modern lens, this philosophy aligns broadly with contemporary interest in proactive wellness management — a growing field focused on helping individuals better understand and maintain their own health before clinical thresholds are reached.

With the development of technologies such as artificial intelligence and big data, TCM physical fitness assessment and health interventions are gradually becoming digital and intelligent. Based on this, FuDe has built a systematic sub-healthy management plan covering everything from identification to intervention, and from maintenance to consolidation.

The AI Four-Diagnosis Instrument: Digitizing the "Look, Listen, Ask, Feel" System

The FuDe AI TCM Four-Diagnostic Device is the technical core of this system. By collecting facial and tongue diagnostic data, combined with voiceprint recognition and intelligent sensing technology for inquiry and pulse diagnosis, the "looking, listening, questioning, and pulse-taking" approach of TCM has been digitised.

FuDe's AI-powered TCM Four Diagnostic Instrument digitizes the traditional diagnostic method through intelligent sensing technology, generating personalized sub-health constitution reports within minutes. (AI-generated image)

The AI relies on a traditional Chinese medicine large model trained on over a million real clinical cases. Based on this, the system can generate personal sub-health constitution reports within 3 to 5 minutes and synchronise them in real time to users' mobile devices. Beyond this professional-grade hardware, Xutang Biotech has also lightened its core algorithms by launching the "FuDe Traditional Chinese Medicine AI Consultation" WeChat mini-program for the general public, making physical fitness assessment truly part of daily life.

International visitors learn about Xutang Biotech's AI-based TCM health screening system at the company's booth.

Academician Zhou Ning, founder and chairman of Xutang Biotech Group, Lifetime Fellow of the Royal Society of Arts (RSA), UK, said in an interview: "We are not trying to replace doctors with AI, but rather using technology to 'translate' millennia of wisdom. Through digital means, we have made the vague concept of 'sub-health' clearly visible, while also making TCM judgment methods quantifiable, standardised, and popularised. Because only when people can 'see' their constitutional imbalances will they become conscious of adjusting their lifestyle."

A Revolution in Application: "Five-Force Integration" for Full-Cycle Health Management

FuDe highlighted its "Five in One" conditioning system for sub-health states. This system does not target specific diseases but relief discomfort caused by high stress, staying up late, anxiety, and other factors, providing a full cycle of care for your health.

This system is summarised into five areas:

• Tea (Tong Tiao Tea): A series of nourishing teas developed from classical TCM formulas, providing daily nourishment tailored to different constitutions.
• Meals (Dietary Packages): Informed by the traditional principle that food and wellbeing are closely connected, integrating dietary choices with constitutional awareness.
• Instruments (Nano Herbal Technology): Leveraging Xutang Biotech's proprietary nano-herbal core technology for targeted concentration of active ingredients.
• Customized Formulations: One-person-one-formula support provided by a team of master TCM practitioners.
• Meridians (Meridian Conditioning): Clearing qi and blood pathways through non-pharmaceutical therapies.

The five dimensions are not simply one after another; rather, they have a dynamic coordination to form a systematic closed loop of health management.

FuDe's "Tong" series herbal teas are formulated according to the traditional Chinese medicine theory, with five blends tailored to different body constitutions. (AI-generated image)

Technology Export: Eastern Wisdom Offering Global Solutions

In 2026, when 'sovereign AI' becomes a buzzword, autonomy, controllability, and standard setting in the healthcare sector will be especially important. FuDe's debut is seen as a technological export and cultural expression by China in the field of traditional medicine modernisation.

"We are not merely offering a tea or a device," said Academician Zhou Ning. "What we present is a philosophy of preventive wellness — a way of thinking about how to support balance before clinical concerns arise, by encouraging attention to the body's natural rhythms. This reflects the essence of TCM's emphasis on constitutional harmony."

Zhou Ning (right), Founder and Chairman of Xutang Biotech Group, engages with international guests at the exhibition.

Starting from the technology exhibition floor at London Olympia, Beijing Xutang Biotech is telling a story about how Eastern medicine and Western technology meet, collide, and grow into new possibilities. When it comes to the global issue of sub-health management, this story may only be just beginning.

Beijing Xutang Biotech (BXB)

The company was founded in 2022, headquartered in Beijing, China and is a high-tech biomedicine company established by Zhou Ning (Yu Jun).

BXB has developed a leading herbal nanomedicine platform integrating extraction, purification, and targeted delivery technologies. The Group collaborates with the National Cancer Centre of China and the China Academy of Chinese Medical Sciences and is committed to advancing healthcare innovation and modernising traditional Chinese medicine.